By vgreene, 28 October, 2021 Hydroxychloroquine for Early Treatment of Adults with Mild Covid 19 A Randomized Controlled Trial
By vgreene, 28 October, 2021 No significant difference in overall sx severity over 14 days or incidence of hospitalization between groups higher rate of ADRs w HCQ 43 vs 22
By vgreene, 28 October, 2021 Double blind multisite RCT 423 non hospitalized pts median age 40y w lab confirmed or probable COVID 19 and
By vgreene, 28 October, 2021 Study considerations internet based surveys in younger pts w mild sx limited testing due to shortage primary endpoint and sample size modified mid study study halted before secondary endpoints medication adherence loss to f u
By vgreene, 28 October, 2021 KEY FINDINGS HCQ did not substantially reduce sx severity in early mild infxn
